{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:40:13Z","timestamp":1788910813881,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2013\/21186-5"],"award-info":[{"award-number":["2013\/21186-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/05286-3"],"award-info":[{"award-number":["2018\/05286-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11033-021-06364-3","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T03:43:50Z","timestamp":1619581430000},"page":"3463-3474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The functional activity of the miR-1914-5p in lipid metabolism of the hepatocarcinoma cell line HepG2: a potential molecular tool for controlling hepatic cellular migration"],"prefix":"10.1007","volume":"48","author":[{"given":"Marina Bonfogo","family":"da Silveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Cristiane","family":"Pansa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osmar","family":"Malaspina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6838-8393","authenticated-orcid":false,"given":"Karen C. M.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"6364_CR1","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/JHC.S61146","volume":"3","author":"J Balogh","year":"2016","unstructured":"Balogh J, Victor D, Asham EH et al (2016) Hepatocellular carcinoma: a review. J Hepatocell Carcinoma 3:41\u201353. https:\/\/doi.org\/10.2147\/JHC.S61146","journal-title":"J Hepatocell Carcinoma"},{"key":"6364_CR2","doi-asserted-by":"publisher","first-page":"9069","DOI":"10.3748\/wig.v22.i41.9069","volume":"22","author":"ZS Niu","year":"2016","unstructured":"Niu ZS, Niu XJ, Wang WH (2016) Genetic alterations in hepatocellular carcinoma: an update. World J Gastroenterol 22:9069\u20139095. https:\/\/doi.org\/10.3748\/wig.v22.i41.9069","journal-title":"World J Gastroenterol"},{"key":"6364_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1128\/mSystems.00153-20","volume":"5","author":"Y Lapidot","year":"2020","unstructured":"Lapidot Y, Amir A, Nosenko R et al (2020) Alterations in the gut microbiome in the progression of cirrhosis to hepatocellular carcinoma. mSystems 5:153\u201320","journal-title":"mSystems"},{"key":"6364_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1155\/2020\/7526042","volume":"2020","author":"MN Protopapa","year":"2020","unstructured":"Protopapa MN, Lagadinou M, Papagiannis T, Gogos CA (2020) Hepatocellular carcinoma: an uncommon metastasis in the orbit. Case Rep Oncol Med 2020:3. https:\/\/doi.org\/10.1155\/2020\/7526042","journal-title":"Case Rep Oncol Med"},{"key":"6364_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","volume":"18","author":"E Currie","year":"2013","unstructured":"Currie E, Schulze A, Zechner R et al (2013) Cellular fatty acid metabolism and cancer. Cell Metab 18:153\u2013161. https:\/\/doi.org\/10.1016\/j.cmet.2013.05.017","journal-title":"Cell Metab"},{"key":"6364_CR6","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1038\/s41419-020-2499-8","volume":"11","author":"S Ye","year":"2020","unstructured":"Ye S, Xu P, Huang M et al (2020) The heterocyclic compound Tempol inhibits the growth of cancer cells by interfering with glutamine metabolism. Cell Death Dis 11:312. https:\/\/doi.org\/10.1038\/s41419-020-2499-8","journal-title":"Cell Death Dis"},{"key":"6364_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/14728222.2019.1615883","volume":"23","author":"IIIa Pope","year":"2019","unstructured":"Pope IIIa, Evans D, Kimbrough EO, Vemireddyc LP et al (2019) Aberrant lipid metabolism as a therapeutic target in liver cancer. Expert Opin Ther Targets 23:473\u2013483. https:\/\/doi.org\/10.1080\/14728222.2019.1615883","journal-title":"Expert Opin Ther Targets"},{"key":"6364_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","volume":"38","author":"C Cheng","year":"2018","unstructured":"Cheng C, Geng F, Cheng X, Guo D (2018) Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun 38:27. https:\/\/doi.org\/10.1186\/s40880-018-0301-4","journal-title":"Cancer Commun"},{"key":"6364_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pharmthera.2017.02.021","volume":"17","author":"D Buckley","year":"2017","unstructured":"Buckley D, Duke G, Heuer TS et al (2017) Fatty acid synthase\u2013modern tumor cell biology insights into a classical oncology target. Pharmacol Ther 17:23\u201331. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.02.021","journal-title":"Pharmacol Ther"},{"key":"6364_CR10","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM (2019) The role of non-coding RNAs in oncology. Cell 179:1033\u20131055. https:\/\/doi.org\/10.1016\/j.cell.2019.10.017","journal-title":"Cell"},{"key":"6364_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1172\/JCI82720","volume":"126","author":"MD Edmonds","year":"2016","unstructured":"Edmonds MD, Boyd KL, Moyo T et al (2016) MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer. J Clin Investig 126:349\u2013364. https:\/\/doi.org\/10.1172\/JCI82720","journal-title":"J Clin Investig"},{"key":"6364_CR12","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/s41467-018-06081-9","volume":"9","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Jiang YY, Xie JJ et al (2018) Co-activation of superenhancer- driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression. Nat Commun 9:3619. https:\/\/doi.org\/10.1038\/s41467-018-06081-9","journal-title":"Nat Commun"},{"key":"6364_CR13","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1158\/0008-5472.CAN-16-1883","volume":"77","author":"KY Hsiao","year":"2017","unstructured":"Hsiao KY, Lin YC, Gupta SK et al (2017) Noncoding effects of circular RNA CCDC66 promote colon cancer growth and metastasis. Cancer Res 77:2339\u20132350. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1883","journal-title":"Cancer Res"},{"key":"6364_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12943-018-0880-3","volume":"17","author":"R Zheng","year":"2018","unstructured":"Zheng R, Du M, Wang X et al (2018) Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression. Mol Cancer 17:143. https:\/\/doi.org\/10.1186\/s12943-018-0880-3","journal-title":"Mol Cancer"},{"key":"6364_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-3-319-22380-3_12","volume":"887","author":"A Lagan\u00e0","year":"2015","unstructured":"Lagan\u00e0 A (2015) Computational prediction of microRNA targets. Adv Exp Med Biol 887:231\u2013252. https:\/\/doi.org\/10.1007\/978-3-319-22380-3_12","journal-title":"Adv Exp Med Biol"},{"key":"6364_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrd.2016.246","volume":"16","author":"R Rupaimoole","year":"2017","unstructured":"Rupaimoole R, Slack FJ (2017) MicroRNA therapeutics: towards a new era for the management of cancer and other diseases. Nat Rev Drug Discov 16:203\u2013222. https:\/\/doi.org\/10.1038\/nrd.2016.246","journal-title":"Nat Rev Drug Discov"},{"key":"6364_CR17","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/978-1-4939-2074-7_5","volume":"1250","author":"MT Donato","year":"2015","unstructured":"Donato MT, Tolosa L, G\u00f3mez-Lech\u00f3n MJ (2015) Culture and functional characterization of human hepatoma HepG2 cells. Methods Mol Biol 1250:77\u201393. https:\/\/doi.org\/10.1007\/978-1-4939-2074-7_5","journal-title":"Methods Mol Biol"},{"key":"6364_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.biocel.2018.02.018","volume":"98","author":"BDO da Silva","year":"2018","unstructured":"da Silva BDO, Alberici LC, Ramos LF et al (2018) Altered global microRNA expression in hepatic stellate cells LX-2 by angiotensin-(1\u20137) and miRNA-1914-5p identification as regulator of pro-fibrogenic elements and lipid metabolism. Int J Biochem Cell Biol 98:137\u2013155. https:\/\/doi.org\/10.1016\/j.biocel.2018.02.018","journal-title":"Int J Biochem Cell Biol"},{"key":"6364_CR19","doi-asserted-by":"publisher","first-page":"e0162094","DOI":"10.1371\/journal.pone.0162094","volume":"11","author":"BO de Silva","year":"2016","unstructured":"de Silva BO, Lima KF, Gon\u00e7alves LR et al (2016) MicroRNA profiling of the effect of the heptapeptide angiotensin-(1\u20137) in A549 lung tumor cells reveals a role for miRNA149-3p in cellular migration processes. PLoS ONE 11:e0162094. https:\/\/doi.org\/10.1371\/journal.pone.0162094","journal-title":"PLoS ONE"},{"key":"6364_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays. J Immunol Methods 65:55\u201363. https:\/\/doi.org\/10.1016\/0022-1759(83)90303-4","journal-title":"J Immunol Methods"},{"key":"6364_CR21","doi-asserted-by":"publisher","first-page":"11300","DOI":"10.1158\/0008-5472.CAN-07-0702","volume":"67","author":"ME Legrier","year":"2007","unstructured":"Legrier ME, Yang CPH, Yan HG et al (2007) Targeting protein translation in human non small cell lung cancer via combined MEK and mammalian target of rapamycin suppression. Cancer Res 67:11300\u201311308. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-0702","journal-title":"Cancer Res"},{"key":"6364_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s12015-020-09963-y","volume":"16","author":"M Parmaksiz","year":"2020","unstructured":"Parmaksiz M, El\u00e7in EA, El\u00e7in YM (2020) Decellularized cell culture ECMs act as cell differentiation inducers. Stem Cell Rev Rep 16:569\u2013584. https:\/\/doi.org\/10.1007\/s12015-020-09963-y","journal-title":"Stem Cell Rev Rep"},{"key":"6364_CR23","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1002\/cber.189502803176","volume":"28","author":"E Fischer","year":"1985","unstructured":"Fischer E, Speier A (1985) Darstellung der ester. Berichte der Dtsch Chem Gesellschaft 28:3252\u20133258. https:\/\/doi.org\/10.1002\/cber.189502803176","journal-title":"Berichte der Dtsch Chem Gesellschaft"},{"key":"6364_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1590\/1414-431X20133028","volume":"47","author":"KK Sakane","year":"2014","unstructured":"Sakane KK, Monteiro CJ, Silva W et al (2014) Cellular and molecular studies of the effects of a selective COX-2 inhibitor celecoxib in the cardiac cell line H9c2 and their correlation with death mechanisms. Braz J Med Biol Res 47:50\u201359. https:\/\/doi.org\/10.1590\/1414-431X20133028","journal-title":"Braz J Med Biol Res"},{"key":"6364_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11010-020-03717-7","volume":"468","author":"CM Silva","year":"2020","unstructured":"Silva CM, Ferrari GD, Alberici LC et al (2020) Cellular and molecular effects of silymarin on the transdifferentiation processes of LX-2 cells and its connection with lipid metabolism. Mol Cell Biochem 468:129\u2013142. https:\/\/doi.org\/10.1007\/s11010-020-03717-7","journal-title":"Mol Cell Biochem"},{"key":"6364_CR26","volume-title":"Spectral properties of lipids","author":"RJ Hamilton","year":"1999","unstructured":"Hamilton RJ, Cast J (1999) Spectral properties of lipids. Blackwell Press, Boca Raton"},{"key":"6364_CR27","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.dsx.2014.09.015","volume":"9","author":"C Janani","year":"2015","unstructured":"Janani C, Kumari BDR (2015) PPAR gamma gene\u2014a review. Diabetes Metab Syndr 9:46\u201350. https:\/\/doi.org\/10.1016\/j.dsx.2014.09.015","journal-title":"Diabetes Metab Syndr"},{"key":"6364_CR28","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.bbalip.2011.09.017","volume":"1821","author":"APL Jensen-Urstad","year":"2012","unstructured":"Jensen-Urstad APL, Semenkovich CF (2012) Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger? Biochim Biophys Acta 1821:747\u2013753. https:\/\/doi.org\/10.1016\/j.bbalip.2011.09.017","journal-title":"Biochim Biophys Acta"},{"key":"6364_CR29","doi-asserted-by":"publisher","first-page":"6924","DOI":"10.1158\/0008-5472.CAN-16-1597","volume":"76","author":"H-P Huai-Peng Lin","year":"2016","unstructured":"Huai-Peng Lin H-P, Cheng Z-L, He R-Y et al (2016) Destabilization of fatty acid synthase by acetylation inhibits de novo lipogenesis and tumor cell growth. Cancer Res 76:6924\u20136936. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-1597","journal-title":"Cancer Res"},{"key":"6364_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1194\/jlr.M081836","volume":"59","author":"AG Linden","year":"2018","unstructured":"Linden AG, Li S, Choi HY, Fei Fang F et al (2018) Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice. J Lipid Res 59:475\u2013487. https:\/\/doi.org\/10.1194\/jlr.M081836","journal-title":"J Lipid Res"},{"key":"6364_CR31","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1681\/ASN.2013030279","volume":"24","author":"PC Sandoval","year":"2013","unstructured":"Sandoval PC, Slentz DH, Pisitkun T et al (2013) Proteome-wide measurement of protein half-lives and translation rates in vasopressin-sensitive collecting duct cells. J Am Soc Nephrol 24:1793\u20131805. https:\/\/doi.org\/10.1681\/ASN.2013030279","journal-title":"J Am Soc Nephrol"},{"key":"6364_CR32","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1194\/jlr.M088419","volume":"59","author":"CN Brocker","year":"2018","unstructured":"Brocker CN, Patel DP, Velenosi TJ et al (2018) Extrahepatic PPAR\u03b1 modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice. J Lipid Res 59:2140\u20132152","journal-title":"J Lipid Res"},{"key":"6364_CR33","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2013.05.017","volume":"13","author":"G Medes","year":"1963","unstructured":"Medes G, Thomas A, Weinhouse S (1963) Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro. Cancer Res 13:27\u201329. https:\/\/doi.org\/10.1016\/j.cmet.2013.05.017","journal-title":"Cancer Res"},{"key":"6364_CR34","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s42255-020-0195-8","volume":"4","author":"A M\u00e9ndez-Lucas","year":"2020","unstructured":"M\u00e9ndez-Lucas A, Lin W, Driscoll PC et al (2020) Identifying strategies to target the metabolic flexibility of tumours. Nat Metab 4:335\u2013350. https:\/\/doi.org\/10.1038\/s42255-020-0195-8","journal-title":"Nat Metab"},{"key":"6364_CR35","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/s41467-019-08777-y","volume":"10","author":"YS Michaels","year":"2019","unstructured":"Michaels YS, Barnkob MK, Barbosa H et al (2019) Precise tuning of gene expression levels in mammalian cells. Nat Commun 10:818. https:\/\/doi.org\/10.1038\/s41467-019-08777-y","journal-title":"Nat Commun"},{"key":"6364_CR36","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.3390\/ijms22031424","volume":"22","author":"VA Stark","year":"2021","unstructured":"Stark VA, Facey COB, Viswanathan V, Boman BM (2021) The role of miRNAs, miRNA clusters, and isomiRs in development of cancer stem cell populations in colorectal cancer. Int J Mol Sci 22:1424. https:\/\/doi.org\/10.3390\/ijms22031424","journal-title":"Int J Mol Sci"},{"key":"6364_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2174\/2211536609666191218103220","volume":"9","author":"B Marengo","year":"2020","unstructured":"Marengo B, Pulliero A, Izzotti Am Domenicotti C (2020) miRNA regulation of glutathione homeostasis in cancer initiation, progression and therapy resistance. MicroRNA 9:187\u2013197. https:\/\/doi.org\/10.2174\/2211536609666191218103220","journal-title":"MicroRNA"},{"key":"6364_CR38","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1101\/gad.233585.113","volume":"28","author":"N Okada","year":"2014","unstructured":"Okada N, Lin CP, Ribeiro MC et al (2014) A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev 28:438\u2013450. https:\/\/doi.org\/10.1101\/gad.233585.113","journal-title":"Genes Dev"},{"key":"6364_CR39","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1038\/sj.emboj.7601790","volume":"26","author":"C Le Sage","year":"2007","unstructured":"Le Sage C, Nagel R, Egan DA et al (2007) Regulation of the p27Kip1 tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J 26:3699\u20133708. https:\/\/doi.org\/10.1038\/sj.emboj.7601790","journal-title":"EMBO J"},{"key":"6364_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ccr.2012.12.020","volume":"23","author":"D Yang","year":"2013","unstructured":"Yang D, Sun Y, Hu L et al (2013) Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell 23:186\u2013199. https:\/\/doi.org\/10.1016\/j.ccr.2012.12.020","journal-title":"Cancer Cell"},{"key":"6364_CR41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.molmet.2020.01.003","volume":"34","author":"D Sengupta","year":"2020","unstructured":"Sengupta D, Cassel T, Teng KY et al (2020) Regulation of hepatic glutamine metabolism by miR-122. Mol Metab 34:174\u2013186. https:\/\/doi.org\/10.1016\/j.molmet.2020.01.003","journal-title":"Mol Metab"},{"key":"6364_CR42","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3390\/ijms22031492","volume":"22","author":"R Mohr","year":"2021","unstructured":"Mohr R, \u00d6zdirik B, Lambrecht J, Demir M, Eschrich J et al (2021) From liver cirrhosis to cancer: the role of micro-RNAs in hepatocarcinogenesis. Int J Mol Sci 22:1492. https:\/\/doi.org\/10.3390\/ijms22031492","journal-title":"Int J Mol Sci"},{"key":"6364_CR43","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol 15:178\u2013196","journal-title":"Nat Rev Mol Cell Biol"},{"key":"6364_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/pharmaceutics13010075","volume":"13","author":"PI Escalante","year":"2021","unstructured":"Escalante PI, Qui\u00f1ones LA, Contreras HR (2021) Epithelial-mesenchymal transition and microRNAs in colorectal cancer chemoresistance to FOLFOX. Pharmaceutics 13:75. https:\/\/doi.org\/10.3390\/pharmaceutics13010075","journal-title":"Pharmaceutics"},{"key":"6364_CR45","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1194\/jlr.D008888","volume":"52","author":"SJR Steven","year":"2011","unstructured":"Steven SJR, Andreo U, Sparks JD, Fisher EA (2011) Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion? J Lipid Res 52:152\u2013158. https:\/\/doi.org\/10.1194\/jlr.D008888","journal-title":"J Lipid Res"},{"key":"6364_CR46","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.3390\/ijms21072632","volume":"21","author":"L Opazo-R\u00edos","year":"2020","unstructured":"Opazo-R\u00edos L, Mas S, Mar\u00edn-Royo G et al (2020) Lipotoxicity and diabetic nephropathy: novel mechanistic insights and therapeutic opportunities. Int J Mol Sci 21:2632. https:\/\/doi.org\/10.3390\/ijms21072632","journal-title":"Int J Mol Sci"},{"key":"6364_CR47","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.molmet.2016.01.001","volume":"5","author":"TA Bowman","year":"2016","unstructured":"Bowman TA, O\u2019Keeffe KR, D\u2019Aquila T et al (2016) Acyl CoA synthetase 5 (ACSL5) ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorption. Mol Metab 5:210\u2013220. https:\/\/doi.org\/10.1016\/j.molmet.2016.01.001","journal-title":"Mol Metab"},{"key":"6364_CR48","doi-asserted-by":"publisher","first-page":"4185","DOI":"10.1038\/s41467-019-12155-z19-12155-z","volume":"10","author":"MR Zanotelli","year":"2019","unstructured":"Zanotelli MR, Rahman-Zaman A, VanderBurgh AG et al (2019) Energetic costs regulated by cell mechanics and confinement are predictive of migration path during decision-making. Nat Commun 10:4185. https:\/\/doi.org\/10.1038\/s41467-019-12155-z19-12155-z","journal-title":"Nat Commun"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06364-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-06364-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-06364-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T12:32:48Z","timestamp":1622637168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-06364-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["6364"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-06364-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"29 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors affirm that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the data in the present study was generated using commercial cell culture.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have seen the manuscript and approved its submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}